Form 8-K - Current report:
SEC Accession No. 0001104659-25-068559
Filing Date
2025-07-17
Accepted
2025-07-17 09:16:11
Documents
13
Period of Report
2025-07-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2520114d1_8k.htm   iXBRL 8-K 25767
2 EXHIBIT 99.1 tm2520114d1_ex99-1.htm EX-99.1 7982
  Complete submission text file 0001104659-25-068559.txt   204160

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snpx-20250717.xsd EX-101.SCH 3020
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE snpx-20250717_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snpx-20250717_pre.xml EX-101.PRE 22362
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2520114d1_8k_htm.xml XML 3802
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
TAO Synergies Inc. (Filer) CIK: 0001571934 (see all company filings)

EIN.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40458 | Film No.: 251129047
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)